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Type 2 diabetes is a complex metabolic disorder characterized by high blood glucose in the context of insulin resistance and
relative insulin deﬁciency by β-cell failure. Even if the mechanisms underlying the pathogenesis of β-cell failure are still under
investigation, recent increasing genetic, experimental, and clinical evidence indicate that hyperactivation of the unfolded protein
response (UPR) to counteract metabolic stresses is closely related to β-cell dysfunction and apoptosis. Signaling pathways of the
UPR are “a double-edged sword” that can promote adaptation or apoptosis depending on the nature of the ER stress condition.
In this paper, we summarized our current understanding of the mechanisms and components related to ER stress in the β-cell
pathogenesis of type 2 diabetes.
1.Introduction
Modernlifestyle,withoverconsumptionofenergy-richfoods
and reduced physical activity, has increased the rate of type
2 diabetes (T2D). T2D is a major cause of morbidity and
mortality, decreasing both life quality and expectancy of
aﬀected individuals. Obesity is linked to insulin resistance
andT2D[1].Inordertoadapttoanincreasedmetabolicload
in obesity and insulin resistance, the normal pancreatic islets
usually increase beta-cell mass through an increase in β-cell
proliferation and neogenesis, as well as beta cell hypertrophy
[2, 3] and enhancing β-cell function [4, 5]. However, failure
of adaptation to the increased metabolic load results in a
progressive decline in β-cell functions and cell death. As
a consequence, individuals progress from normal glucose
tolerance to impaired glucose tolerance and ﬁnally to
established T2D [6, 7]. Accumulating evidence indicates that
β-cell loss in T2D results from intertwined stress responses
of gluco-/lipotoxicity, oxidative stress, and ER stress [6–14].
However, detailed molecular mechanisms underlying β-cell
dysfunction and death remain to be clariﬁed.
2. The Unfolded ProteinResponse inβ Cells
The endoplasmic reticulum (ER) is a major subcellular com-
partment involved in calcium storage, lipid production,
and protein biosynthesis in which a variety of extracellular
signaling molecules and protein receptors critical for cellular
homeostasis are properly folded, assembled, matured, and
ﬁnally transported to their destination to function. These
processes rely on the protein folding activity of chaperones
densely populated in the ER [13]. However, folding activity
can be overwhelmed with the amount of proteins im-
ported into the ER under the instance of “ER stress”,
during which unfolded proteins accumulate in the ER and
trigger downstream signaling pathways, which is called
the unfolded protein response (UPR) [15]. The UPR is
triggered by three ER stress signaling transducers—PKR-
like ER kinase (PERK, EIF2AK3), inositol requiring 1α
(IRE1α), and activating transcription factor 6α (ATF6α)—
on the ER membrane, resulting in attenuation of protein
translation and transcriptional activation of UPR genes
[15]. In addition, cells activate a pathway to dispose of2 Experimental Diabetes Research
misfolded proteins from the ER, termed “ER-associated
degradation (ERAD)” [16]. Regulation of these processes
from biosynthesis to degradation is required for protein
homeostasis, and disruption in these processes can lead to
terminal misfolding and/or aggregation of proteins in the
ER. Then, terminally misfolded proteins which cannot be
dealt by ERAD machineries need to be cleared from the
ER by an additional process such as autophagy [17]. Thus,
the adaptive pathways maintain cellular function and avoid
apoptosis during ER stress. However, if ER stress is severe
and chronic, UPR-mediated eﬀorts to correct the protein
foldingdefectfail,andtheapoptoticpathwayispreferentially
activated over time [18, 19].
Increasing evidence indicates that ER stress is associated
with a variety of diseases including diabetes, neurodegen-
erative disease, cancer, bipolar disease, liver disease, cardiac
disease, muscle degeneration, autoimmune disease, and
others [20, 21]. Several scientists have found evidence that
T2D may be an example of an important human disease
caused by ER stress [22, 23]. T2D occurs in patients who
fail to compensate for insulin resistance by increasing insulin
secretion.Therefore,pancreaticβ-celldysfunctionandapop-
tosis are central to T2D pathogenesis. In this paper, we will
discussthecomplexERstressresponsesresponsibleforβ-cell
protection as well as dysfunction and death during T2D.
2.1. Three Stress Response Pathways in the UPR. Cells have
evolved an intertwined three cellular pathway termed “the
unfolded protein response” to prevent accumulation of
misfolded proteins in the ER lumen. ER stress such as
misfolded protein accumulation is sensed by the luminal
domains of three ER transmembrane proteins: PERK, IRE1α
andATF6α.Thenactivatedstresssensorsinitiatethecomplex
signaling pathways (Figure 1)[ 15].
2.1.1. PERK Pathway. During ER stress, PERK is disso-
ciated from GRP78 (BiP), an abundant ER chaperone,
then multimerizes and autophosphorylates [24]. Activation
of PERK leads to phosphorylation of the alpha subunit
of eukaryotic initiation factor 2 (eIF2α), which is an early
response required for the attenuation of global protein
translation in response to ER stress aimed to prevent further
overload of the nascent polypeptides to be folded in the
ER lumen [15, 25, 26]. PERK, on the other hand, induces
eﬃcient translation of several speciﬁc transcripts (such as
cationic amino acid transporter 1 (cat-1), growth arrest, and
DNA damage 34 (GADD34), ATF5, and ATF4) even under
the condition of signiﬁcant eIF2α phosphorylation [27–
29]. Among them, translational increase of ATF4 induces
expression of several genes involved in ER protein folding,
ERAD, amino acid biosynthesis and transport function, and
antioxidative stress response. Thus, translational inhibition
to general mRNA transcripts but translational activation
to speciﬁc mRNA transcripts by PERK is an important
component of the UPR-mediated adaptation pathways to
ER stress [29, 30]. Therefore, PERK activity and eIF2α
phosphorylation are particularly important to maintain
functionofpancreatic β-cells,whichcontinuouslysynthesize
and secrete large amounts of insulin molecules according to
physiological ﬂuctuation of blood glucose [29, 31]. Several
studies discussed below have shown that disruption of their
activities increases susceptibility of β cells to death and
induces β-cell failure associated with insulin resistance in
T2D [23, 32, 33]. In contrast, PERK also induces expression
of CHOP through transcriptional activation by ATF4 [34],
an important proapoptotic gene of ER stress-mediated β-cell
death [35, 36]. Therefore, it is now believed that the PERK-
mediated signaling pathway may behave like a binary switch
determining life and death of β cell depending on the nature
of ER stress condition.
2.1.2. IRE1α Pathway. The luminal domain of PERK is func-
tionally interchangeable in transmitting ER stress signal
with IRE1α, another ER sensor, from which GRP78 is
released upon exposure to ER stress [24]. IRE1α, like PERK,
is autophosphorylated and dimerized by its cytoplasmic
kinase domain as misfolded proteins in the ER accumulate,
leading to activation of the C-terminal ribonuclease domain
and speciﬁc cleavage of mRNA encoding a basic leucine zip-
per containing transcription factor X-box-binding protein
(XBP1) [37–39]. The spliced Xbp1 mRNA encodes a strong
transcription factor (XBP1s) for many UPR genes important
in protein folding, traﬃcking, secretion, and ER-associated
degradation [40–42]. Therefore, the transcriptional function
of XBP1s is important for many professional secretory
cells, particularly, β cells [42, 43]. Thus, the IRE1α-XBP1
pathway contributes to restoring ER homeostasis to meet
protein folding demand and protein transport [44]. Beside
homeostatic function, IRE1α, under chronic ER stress,
also activates proapoptotic c-Jun N-terminal kinase (JNK)
signaling pathway and interacts with members of the B-
cell lymphoma 2 (BCL2) family, causing cellular dysfunction
and apoptosis [15, 45]. Moreover, it has been shown more
recently that endonuclease activity of IRE1α cleaves ER-
localized mRNAs, including proinsulin mRNA, resulting in
β-cell dysfunction and apoptosis [46, 47].
2.1.3. ATF6 Pathway. The stress sensors mediating the third
UPR pathway activating transcription factor α (ATF6α)a n d
ATF6β, a structural homologue of ATF6α [48], are also
associated with GRP78 and retained in the ER membrane.
During ER stress, both proteins released from GRP78
traﬃc to the Golgi apparatus [49, 50] from which their
active cytosolic fragments (p50ATF6α and p60ATF6β)a r e
generated by S1P and S2P protease and migrate into the
nucleus [51]. Although the activation mode of ATF6β during
ER stress seems the same to ATF6α and biochemical studies
toATF6βsuggestithassimilarbiologicalfunctionstoATF6α,
analysis of mouse embryonic ﬁbroblasts (MEFs) deﬁcient
in ATF6α or ATF6β revealed that ATF6α but not ATF6β
is responsible for transcriptional induction of ER chaperones
including GRP78 and that p50ATF6α heterodimerized with
XBP1s are capable of binding both ER stress response
element (ERSE) and UPR elements (UPRE) conserved in the
promoters of UPR genes, resulting in signiﬁcant activation
of genes to restore proper ER function, protein folding,Experimental Diabetes Research 3
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Figure 1: Activation of cellular responses during ER stress. In the resting state, newly synthesized polypeptides are cotranslationally trans-
located from the ribosome to the inside of the ER, in which GRP78 (BiP) plays two very important roles. First,GRP78 interacts and stabilizes
polypeptides entering the ER and facilitates their proper folding, assembly, and maturation. Second, GRP78 interacts with PERK, IRE1α,
and ATF6α, making them stay monomeric and functionally inactive on the membrane. However, these interactions are sensitive to protein
folding status and can be easily disrupted by accumulation of misfolded proteins in the ER, resulting in activation of several pathways for
protecting cells from accumulation of misfolded proteins: UPR, ERAD, and pQC. The pQC pathway is characterized by substrate-speciﬁc
inhibitionofproteintranslocationduringERstress,resultingineﬃcientdegradationofmistranslocatedproteinsinthecytosol.Thispathway
isphysiologicallyimportantintermsofcontrollingproteinquantityindamagedER.FollowingdissociationofGRP78fromERstresssensors
under ER stress, cells activate the UPR pathways to transfer signals to the nucleus and cytosol. PERK and IRE1α are autophosphorylated
and modify their downstream signaling molecules, eIF2α phosphorylation, and Xbp1 mRNA splicing, respectively. Phosphorylated eIF2α
attenuates general protein translation in short. In addition, accumulation of phosphorylated eIF2α induces ATF4 expression. Together with
ATF4, spliced XBP1 and cytosolic fragments of ATF6α (p50) transcriptionally activate various UPR genes involved in either adaptation or
apoptosis during ER stress.
and ERAD [52, 53]. However, double knockout of ATF6α
and ATF6β caused embryonic lethality whereas ATF6α-or
ATF6β-deﬁcient mice are dispensable for embryonic and
postnataldevelopment,respectively,theseresultssuggestthat
ATF6α and ATF6β possess at least an overlapping function
which is essential for mouse development [52, 53]. Although
ATF6α-null murine model did not show pancreatic β-
cell demise from functional deﬁciency of ATF6α [52, 53],
hyperactivation of ATF6α decreases insulin gene expression
via upregulation of the orphan nuclear receptor small
heterodimer partner (SHP; NR0B2) which has been shown
to play a role in β-cell dysfunction [54].
3. ERADandNon-ERAD Mechanisms
The UPR involves three distinct mechanisms, namely tran-
scriptional induction of ER-resident chaperones to facilitate
protein folding, translational attenuation to decrease the
demand of protein folding, and ERAD to degrade the
unfolded proteins accumulated in the ER lumen. Emerging
data now indicate that the function of the UPR restoring
ER homeostasis is facilitated by both ERAD and non-
ERAD (such as autophagy and preemptive quality control)
mechanisms to remove aggregated proteins from the ER and
reduce new substrates during stress. Thus, eﬃcient removal
of misfolded proteins is essential to protect cells from ER
stress. Here, we will review the protein degradation pathways
associated with the ER.
3.1.ER-AssociatedDegradation(ERAD)Pathway. Eukaryotic
cellshave proteinqualityandquantity controlsystemsaimed
to dispose of misfolded proteins from the ER [55]. Conse-
quently,chaperonesintheERdistinguishphysicaldiﬀerences
between properly folded and unfolded proteins in the ER
[56,57].Hsp70-type(suchasGRP78)andglycan-dependent
chaperones (such as calreticulin and calnexin) bind unfolded
proteins and contribute to maintain solubility of substrates,
leading to remodeling of proteins that have incorrect con-
formation [57–59]. Eﬃcient removal of misfolded proteins
by the ERAD pathway seems to be very speciﬁc because
it directly deals with speciﬁc substrates and, apparently,
is essential to protect cells from ER stress and restore4 Experimental Diabetes Research
proper ER function. Several distinct steps complete this
pathway. First, although the mechanism selecting substrates
is still under investigation, when cells recognize terminally
misfolded proteins unable to acquire their native structures
[60], ER-mannosidase I (ERManI) and mannosidase-like
proteins (EDEMs) ﬂag a target glycoprotein for degradation
and activate the degradation pathway thereafter [61–63].
Second, substrates are retrotranslocated across the ER mem-
brane via multicomplex channels, including Sec61, Derlin-
1, or E3 ubiquitin ligase family members [64–66]. Third,
target proteins are ubiquitylated by an E3 ligase. Finally,
targetproteinsarethenremovedfromtheERmembraneand
transported to the proteasome for degradation. Although
the importance of the ERAD mechanism in pancreatic
β-cells has not been studied extensively, recent studies
suggest that defective protein degradation by reduction of
ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1) activity
can compromise viability in β cells in T2D. Downregulation
of UCH-L1 expression and activity in β cells induces ER
stress and apoptosis [67]. In addition, E3 ubiquitin ligase
HRD1 may have a protective role as an ubiquitin ligase for
ATF6α [68], which inhibits hyperactivation of ATF6α in the
islets of WFS1-deﬁcient mice.
3.2. Autophagy. While ERAD controls the degradation of
smaller units of unfolded and misfolded proteins, larger ag-
gregates and long-lived proteins are detoxiﬁed via degra-
dation in the lysosome, a process called autophagy [69].
Autophagy was originally identiﬁed as a dynamic process
for degradation of cytosolic organelles [70]. Now it has
also been addressed as an additional degradation pathway
for proteins strongly linked to the UPR pathway [69]. For
example, the phosphorylation of eIF2α is also required
for the induction of autophagy [71]. Therefore, ER stress
stimulates autophagy as an adaptive response to clean up
terminally misfolded proteins from the ER.
3.3.PreemptiveQualityControl(pQC). Inadditiontotypical
quality control pathway in mammals such as ERAD, a new
degradation pathway for secretory proteins has recently been
discovered. During acute ER stress, some secretory and
membrane proteins are rerouted in a signal sequence-se-
lectivemannerfromitsnormalfateofbeingtranslocatedinto
the ER to a pathway of proteasome-mediated degradation.
Theircotranslationalreroutingtothecytosolfordegradation
reduces the burden of misfolded substrates entering the ER,
termed this process pre-emptive quality control (pQC) [72]
For example, prion protein (PrP) is mistranslocated and
rerouted to the cytosol for immediate degradation by the
proteasomeduringERstress.Thisprocessislargelyregulated
by the speciﬁc signal sequence of proteins [72, 73].
Eﬃcient UPR pathway activated at the early stage of
ER stress readily remodel misfolded proteins and restore
proper ER function. As ER stress is excessive and prolonged,
terminally misfolded proteins are disposed of from the ER
by the ERAD pathway. At the same time, the pQC pathway
reroutes misfolded proteins from the ER to the cytosol
for degradation, leading to a reduction in the burden of
ERAD
pQC Degradation
Autophagy
Figure 2: Potential activation mechanisms for disposing misfolded
proteins from the ER. Misfolded proteins in the ER can be disposed
of by serial activation of ERAD, pQC and autophagy according
to the degree of protein misfolding and aggregation. In general, a
small amount of protein is spontaneously misfolded and eﬃciently
degraded in the ER even in the resting state. Under ER stress,
accumulation of misfolded proteins in the ER activates pQC to
reduce the burden of proteins in damaged ER as well as the ERAD
pathway to dispose of misfolded proteins from the ER. However,
underprolongedERstress,ERADdoesnoteﬃcientlydisposeofand
degradeproteinaggregatesfromtheER,resultinginactivationofan
alternative way to clean them up from the ER, called “autophagy”.
Activation of these pathways is aimed at increasing ER capacity for
protecting cells from misfolded proteins.
misfolded substrates entering the ER. Therefore, when the
UPR and/or ERAD pathways are compromised, the pQC
pathway is apparently beneﬁcial for cells under ER stress
(Figure 1). Furthermore, to remove large aggregations, cells
activate autophagy by which a large portion of aggregations
can be transported directly to lysosomes for degradation
without passing through the Golgi (Figure 2). However, ter-
minally misfolded proteins often accumulate and aggregate
in the ER. When the previously mentioned protein degra-
dation mechanisms are not functionally eﬃcient in dealing
with the increasing amount of substrates, cells fail to be
rescued from accumulation of misfolded proteins in the ER
and cytosol. This may activate several ER stress-mediated
pro-apoptoticpathwaysresultinginthedeathofstressedcells
[74].
4.Roles ofUPR-RelatedGenesinβ Cells
4.1.PERK/eIF2αPathway. Ararehumanautosomalrecessive
genetic disorder, the Wolcott-Rallison syndrome, is char-
acterized by early infancy diabetes, multiple epiphyseal dys-
plasia, and growth retardation [75, 76]. These patients have
endocrine and exocrine insuﬃciency and pancreatic atrophy
with reduced number of β-cells [77, 78]. This syndrome was
found to be associated with mutations in the Perk gene. In
addition to that, linkage between diabetes and Perk gene
was reported in Scandinavian families [79] and South Indian
populations [80].
In addition to human studies, investigations using
PERK−/− mice and mice (Ser51Ala) with mutation in the
phosphorylation site of eIF2α showed a potential relation-
ship between ER stress and β-cell function [29, 30, 81].
Pancreatic β cells developed normally in whole body Perk-
null mice but showed a diabetic phenotype soon after birth
mainly due to β-cell death [30, 81, 82]. In these studies, ER
distention was observed in pancreatic β cells. In addition,Experimental Diabetes Research 5
there was more proinsulin production in Perk−/− β cells
challenged by high glucose, causing them to experience
higher translational loads and higher levels of ER stress
than wild type. These results suggested that ER overload
and unresolved ER stress may cause β-cell death in those
mice.ConditionaldeletionofPerk atdiﬀerentdevelopmental
stagesshowed thatPERKexpression in β-cellsis notrequired
postnatally in adult mice to maintain glucose homeostasis,
whereas its expression is a prerequisite for fetal/neonatal β
cell proliferation and diﬀerentiation [82].
Similar to Perk−/− mice, eIF2α homozygous mutant mice
showed deﬁciency in pancreatic β cells in the embryonic
stage, and they died within 18hr after birth [29]. Moreover,
the β cells of late embryonic stage in the mutant mice have
reduced insulin contents and show severe distension of the
ER [31, 33]. The results suggest that function of eIF2α
phosphorylation may be required for β-cell diﬀerentiation
and proliferation, along with embryonic β cells of Perk−/−
mice. However, recent results showed that eIF2α phospho-
rylation but not PERK expression in β c e l l si sr e q u i r e da t
the adult stage to maintain β-cell functions and glucose
homeostasis.TheabsenceofeIF2αphosphorylationinβ cells
caused defective intracellular traﬃcking of ER cargo pro-
teins, increased oxidative damage, and reduced expression
of stress response and β-cell-speciﬁc genes and apoptosis
due to heightened and unregulated proinsulin translation
[33]. Since Ser51Ala homozygous mutation in eIF2α (A/A)
does not allow any compensatory phosphorylation by other
eIF2αkinases(suchasheme-regulatedinhibitorkinase(HRI,
EIF2AK1), general control of nitrogen metabolism kinase
2 (GCN2, EIF2AK4), and dsRNA-activated protein kinase
(PKR, EIF2AK2)) [83]i na d u l tβ cells in response to phys-
iological stimuli, whereas other eIF2α kinase in PERK-
deﬁcientadultβ cellsmightcompensatetherequirementsfor
eIF2α phosphorylation. This characteristic might contribute
to phenotypic discrepancies between Perk−/− and A/A mice.
The heterozygous mutant (S/A) mice did not spontaneously
develop diabetes; however, on a 45% high fat diet, these
mice showed glucose intolerance and insulin secretion defect
in β cells [31]. These results suggested that translational
regulation through eIF2α phosphorylation is required to
maintain functional integrity of the ER. This hypothesis was
further demonstrated by a study using mice with conditional
A/A mutation in β cells [33]. The A/A mice were rescued by
transgenic expression of wild-type eIF2α cDNA, which could
be speciﬁcally deleted in β cells by tamoxifen-inducible Cre
recombinase. As early as 3 weeks after deletion of wild-type
eIF2α cDNA, β cells showed signiﬁcantly distended ER and
swollen mitochondria [33].
4.2. WFS1. Wolfram syndrome (WFS) is a rare autosomal
recessive neurodegenerative disorder characterized by early
onset diabetes, optic atrophy, and hearing impairment [84].
This syndrome is genetically linked with mutations in the
Wfs1 gene that encodes the protein wolframin [85, 86]. As
in human cases, mice deﬁcient in the Wfs1 gene developed
glucose intolerance and overt diabetes due to insuﬃcient
insulin secretion. Pancreatic β cells in mutant mice expe-
rienced ER stress shown by phosphorylation of eIF2α and
spliced form of XBP1 [87–89]. Recent study suggests that
WFS1 may aﬀect maturation of plasma membrane proteins
or stability of ER membrane proteins. Deﬁciency of WFS1
in β cells destabilizes Na+/K+ ATPase β1 subunit and E3
ubiquitin ligase HRD1 [68, 90]. Thus, wolframin may be
involved in the ER folding and assembly of subunits of
oligomeric proteins. In addition, Wolframin may suppress
ATF6α hyperactivation in β cells by stabilizing HRD1, which
brings ATF6α to the proteasome. Therefore, WFS may have
a role as a negative regulator of chronic or unresolvable ER
stress.
4.3. P58IPK. Although p58IPK (IPK, inhibitor of protein kin-
ase) was ﬁrst known to be an inhibitor of the PKR, its
function has been shown to inhibit another eIF2α kinase,
PERK. However, recent evidence suggests that p58IPK serves
as a cochaperone in the ER lumen for the Hsp70 family
member BiP [91]. Mice lacking the p58IPK gene showed
gradual onset of glucosuria and hyperglycemia mainly due
to apoptosis of pancreatic β cells [92]. In addition, p58IPK
deletion in Akita mice (carrying a C96Y mutation in the Ins2
gene) exacerbate the diabetic phenotype [93]. These results
indicate that chaperoning ability in the ER is important to
preserve ER function in β cells.
4.4. ATF6α. ATF6α was also found to be associated with β-
cell function in genetic studies. In a study of Pima Indians,
a native American population with a high prevalence of
type II diabetes, [94] they found an association of variants
in ATF6 with T2D [95]. In another study conducted in a
Dutch cohort, they also found that the majority of single
nucleotide polymorphisms (SNPs) in Aft6 allele were sig-
niﬁcantly associated with impaired fasting glucose, impaired
glucose tolerance, and T2D [96]. Furthermore, associated
variants diﬀered from those identiﬁed in the Pima Indians.
Since ATF6α is important for protective cell response to
accumulation of unfolded and misfolded proteins in the
ER, disturbances of this process might contribute to β-cell
apoptosis. However, there is no direct evidence of pancreatic
β-cell demise in the ATF6α null murine model.
5. Causes of ERStress in β Cell
IncreasingevidenceindicatesthatERstressisoneofthemain
causes of β-cell dysfunction and death [6–14]. However, it
is not clear what is the main cause of ER stress in β cells,
andwhichsubpathwayofUPRisresponsibleforthisprocess.
In this section, we will describe the potential sources and
mechanisms for ER stress-mediated β-cell demise.
5.1. Lipotoxicity-Mediated ER Stress. Hyperlipidemia (ele-
vated serum lipid levels) also results from sustained insulin
resistance. It is thought that chronically elevated levels of
circulating free fatty acids (FFAs) are putative mediators
of progressive β-cell dysfunction and death in T2D [97].
When FFA levels are elevated twofold above the basal
upon lipid infusion, obese nondiabetic individuals showed6 Experimental Diabetes Research
a signiﬁcant reduction in glucose-stimulated insulin release
[98]. It has recently been shown that a saturated long-chain
FFA palmitate induces ER stress in both clonal and primary
murine and human β cells, whereas unsaturated long-chain
FFAs do or do not induce ER stress to a lesser content [10,
11,99,100].PalmitatepreferentiallyactivatesbothPERKand
IRE1α pathways [101–103]. However, it is uncertain whether
palmitate can speciﬁcally activate the ATF6α branch because
both palmitate and oleate induce total Xbp1 mRNA, and the
expression of the known ATF6α target gene Hspa5 (Grp78)
is controversial [102, 104]. How saturated FFAs activate the
unfolded protein response has not been answered. Several
recent studies indicate that palmitate triggers ER stress in β
cells through perturbation in ER Ca2+ handling. Calcium-
speciﬁc dye assays revealed palmitate depletes ER Ca2+ and
slows ER Ca2+ uptake in β cells [104]. Although palmitate-
mediated ER Ca2+ depletion increased misfolded protein
accumulation as the mechanism of the sarco-/endoplasmic
reticulum Ca2+-ATPase(SERCA)inhibitorsthapsigarginand
cyclopiazonicacid,twocommonlyknownsyntheticERstres-
sors,thedetailedmolecularmechanismofERCa2+ depletion
by palmitate is not well known. Other reports indicated
palmitate rapidly increases the saturated lipid content of the
ER, leading to compromised ER morphology and integrity
and thereby may directly or indirectly induce ER stress [100,
105]. For example, impairment of lipid content control of
the ER by palmitate hampers ER-to-Golgi protein traﬃcking
of vesicular stomatitis virus G protein (VSVG), contributing
to the unfolded protein response through accumulation of
misfolded proteins in the ER lumen [106]. Interestingly,
increased fatty acid desaturation by stearoyl coenzyme A
desaturase 1 (SCD1) reduced palmitate-induced cell death
in MIN6 β cells and human embryonic kidney (HEK) cells
[107]. In contrast, knockdown of SCD in INS-1 β cells
decreased desaturation of palmitate to monounsaturated fat-
tyacid(MUFA),loweredfattyacidpartitioningintocomplex
neutral lipids, and augmented palmitate-induced ER stress
and apoptosis [108]. Furthermore, the importance of lipid
content control of the ER by SCD in β cells was further
manifestedbystudiesofdiabeticmurinemodels.First,lossof
SCD1 worsens diabetes in leptin-deﬁcient obese mice [109].
Second, SCD1 and SCD2 mRNA expression were shown
to be induced in islets from prediabetic hyperinsulinemic
Zucker diabetic fatty (ZDF) rats, whereas several fatty acid
desaturases including SCD1 mRNA levels were markedly
reduced in diabetic ZDF rat islets [108].
5.2. Misfolded Protein-Mediated ER Stress. Since proinsulin
represents up to 20% of the total mRNA and 30–50% of
the total protein synthesis in the β cell [110–112], misfolded
mutant insulin proteins might be a potent cause of ER
stress. The Akita mutant in both mouse and human, which
carries a cysteine 96 to tyrosine substitution in the Ins2 gene,
showed hyperglycemia and a reduced β cell mass [35]. This
missense mutation disrupts a disulﬁde bond formation of
mature insulin causing incorrect folding of proinsulin in
the ER. Accumulation of the mutant insulin induced cell
death mainly through ER stress evidenced by upregulated
expression of ER stress marker genes such as BiP, spliced
XBP1s, activated ATF6α, and CHOP in the Akita mutant
islets and β-cell lines [113–115]. In heterozygous, but
not homozygous, Akita’s mutant mice, the homozygous
disruptionofCHOPdelayeddiabetesdevelopmentsuggested
that β-cell death is partially CHOP dependent [93].
Similar to Akita diabetes due to accumulation of mis-
foldedproinsulin,ERaccumulationofisletamyloidpolypep-
tide (IAPP, amylin) oligomers may contribute to β-cell loss
in T2D [12]. Human IAPP is an 89 amino acid protein
that undergoes processing to a 37-amino acid amyloidogenic
peptide coexpressed and cosecreted with insulin by β cells.
A study showed that islet amyloid is present at autopsy in
over than 90% of patients with T2D [8]. Moreover, increased
expression of ER stress marker genes such as BiP and CHOP
was observed in islets of human T2D patients [22]. The
IAPP-driven ER stress theory was exempliﬁed by animal
studies overexpressing human IAPP in β cells. Human IAPP
but not murine IAPP forms toxic oligomers and triggers
ER stress-induced apoptosis in β cells of both rat and
mouse murine models [12]. Therefore, intracellular deposit
of human IAPP toxic oligomer could be a link between ER
stress and β-cell death in human T2D.
5.3. High Glucose-Mediated ER Stress. Insulin resistance in
T2D causes blood glucose levels to remain high [116]. In
a high blood glucose state, called hyperglycemia, the β-
cell increases its metabolic activity, which eventually leads
to cellular stress. This in turn may further impair β-cell
function and survival, a process called glucotoxicity [117]. It
has been shown that glucotoxicity is mediated at least in part
by excess generation of reactive oxygen species (ROS) [117,
118]. When excess glucose is available to the β cell, excessive
ROS can be generated in β cells by several biochemical
pathways including mitochondrial oxidative phosphoryla-
tion, ER oxidative folding pathway, and other alternative
metabolism pathways; overﬂowed glucose is shunted (such
as glucosamine and hexosamine metabolism and sorbitol
metabolism) [117, 118]. Elevated ROS perturbs insulin syn-
thesis and secretion by decreasing the expression and activity
of key transcription factors such as PDX-1 and MafA, which
regulate proinsulin genes and other multiple genes involved
in β-cell diﬀerentiation, proliferation, and survival [119].
Accumulating evidence suggests that protein folding in
the ER and production of ROS are closely linked events
[120]. In several reports, prolonged UPR activation leads
to the accumulation of ROS via two sources: the UPR-
regulated oxidative protein folding machinery in the ER
and oxidative phosphorylation in mitochondria [118, 121].
In the ER lumen, oxidative protein folding is conducted
by protein disulﬁde isomerase (PDI) and a family of ER
oxidoreductases 1 (ERO1) that catalyze disulﬁde bond for-
mation in folding proteins. In this reaction, an oxidant ﬂavin
adenine dinucleotide (FAD)-bound ERO1 oxidizes PDI,
which then subsequently oxidizes folding proteins directly.
FAD-bound ERO1 then passes two electrons to molecular
oxygen, perhaps resulting in the production of ROS such
as hydrogen peroxide or peroxide [120]. OverexpressionExperimental Diabetes Research 7
of a misfolded protein CPY (yeast vacuolar protein car-
boxypeptidase Y) activates the UPR, causes oxidative stress,
and induces apoptosis. However, removal of all cysteine
residues in CPY reduced oxidative stress and cell death
[122]. Therefore, oxidative protein folding in the ER can
be a source of ROS generation. It is known that ER stress
increase leakage of Ca2+ from the ER lumen through mainly
the inositol-1,4,5-trisphosphate receptor (IP3R) [21]. Recent
studiessuggestthatERCa2+ leakagemayoccurbyoxidation-
induced activation of the Ca2+ release channel IP3R during
ER stress and oxidative stress [123]. Increases in cytosolic
Ca2+ can stimulate mitochondrial ROS production through
multiple mechanisms [124]. Introduced by Ca2+ uniporter
or mitochondrial ryanodine receptor, Ca2+ stimulates the
TCA cycle and nitric oxide synthase (NOS), which sub-
sequently generates nitric oxide. Nitric oxide and Ca2+
inhibits respiration complex I, III, or IV, which enhance
ROS generation. High levels of ROS generation within the
mitochondria then further increase Ca2+ release from the
ER. In turn, Ca2+ also dissociates cytochrome c from the
inner membrane cardiolipin, which triggers permeability
transition pore (PTP) opening and cytochrome c release
across the outer membrane. Now the vicious cycle of ER
Ca2+ release and mitochondrial ROS production activates
cytochrome-c-mediated apoptosis. The ER of diabetic pan-
creatic β cells synthesizing great quantities of proinsulin
to maintain normoglycemia can be an important site of
ROS production because correct folding of proinsulin ab-
solutely depends on the formation of disulﬁde bond by
oxidative protein folding. This theory is partially supported
by recent reports that PERK and eIF2α phosphorylation-
deﬁcient β cells having reduced UPR responses showed
increased proinsulin synthesis due to losing of translational
control; thereby, large accumulation of proinsulin in the ER
attributed to accumulated ROS in β cells possibly by both
ER oxidative protein folding machinery and Ca2+ mediated-
mitochondria activation [33, 82]. Thus, excess ROS and the
mitochondrial cell death pathway may induce β-cell death.
Therefore, the ﬁnding that increased proinsulin synthesis
causes oxidative damage in β cells may reﬂect events in β-cell
failure associated with insulin resistance in T2D [74].
Under high glucose conditions, it is possible that
increased proinsulin biosynthesis may overwhelm the
ER protein folding capacity leading to UPR activation.
Chronic exposure (more than 24hrs) of β cells to
high-glucose caused hyperactivation of IRE1α showing
Xbp1 mRNA splicing, whereas acute expose (1–3hrs)
to high glucose activated IRE1α without Xbp1 mRNA
splicing [47, 118, 125]. In the chronic high-glucose state,
activated IRE1α degrades proinsulin mRNA contributing
to the reduction of proinsulin biosynthesis [47, 125].
Moreover, recent reports suggest that IRE1α’s RNase causes
endonucleolytic decay of many ER’s localized mRNAs,
including those encoding chaperones, thereby culminating
in cellular dysfunction and death of several mammalian
cells including β cells [46, 47, 125]. However, the studies
also revealed that activated IRE1α at the physiological level
may have a beneﬁcial eﬀect aiding in the enhancement
of proinsulin biosynthesis in pancreatic β c e l l sw i t ht h e
induction of a subset of downstream genes of IRE1α [47].
Thus, depending on the forms of ER stress, β cells may
generate binary signaling of life and death through IRE1α.
It is well established that high blood sugar ampliﬁes FFA-
mediated toxicity in β cells [117, 118]. Although why glucose
exacerbates β-cell lipotoxicity is not well known, a recent
reportsuggeststhatchronichyperglycemiamayamplifyfatty
acid-induced ER stress in β cells [101]. The study showed
that high glucose ampliﬁes palmitate-mediated stimulation
of the IRE1α and PERK pathways. Glucose stimulates the
mammalian target of rapamycin complex 1 (mTORC1), an
importantnutrientsensorinvolvedintheregulationofcellu-
lar stress, and the activated mTORC1 mediates ampliﬁcation
of fatty acid’s lipotoxicity by increasing IRE1α protein levels
and activating the JNK pathway, leading to increased β-cell
apoptosis.
6. Concluding Remarks
Increasing evidence indicates that hyperactivation of the
UPR indispensible for ER homeostasis has a role in β cell
dysfunction and death during the progression of T2D and
genetic forms of diabetes. Therefore, it is currently believed
that ER stress-related diseases including T2D occur from
adaptation to apoptosis of stressed cells. The complete
understanding of this molecular mechanism responsible for
life and death will shed light on future T2D prevention and
treatment.
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